TRIFERIC FERRIC PYROPHOSPHATE CITRATE Trademark

Trademark Overview

On Thursday, April 2, 2015, a trademark application was filed for TRIFERIC FERRIC PYROPHOSPHATE CITRATE with the United States Patent and Trademark Office. The USPTO has given the TRIFERIC FERRIC PYROPHOSPHATE CITRATE trademark a serial number of 86585130. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, September 21, 2022. This trademark is owned by ROCKWELL MEDICAL. The TRIFERIC FERRIC PYROPHOSPHATE CITRATE trademark is filed in the Pharmaceutical Products category with the following description:

Preparations for use in clinical and medical dialysis procedures; pharmaceutical solutions used in dialysis and hemodialysis; pharmaceutical preparations, namely, preparations for treating iron deficiency, anemia, kidney disease and renal disease; pharmaceutical preparations for injection, namely, preparations for treating iron deficiency, anemia, kidney disease and renal disease; iron delivery therapy, namely, commercial iron nutritional supplements, intravenous fluids used for the delivery of iron and soluble ferric pyrophosphate, all goods containing ferric pyrophosphate citrate
triferic ferric pyrophosphate citrate

General Information

Serial Number86585130
Word MarkTRIFERIC FERRIC PYROPHOSPHATE CITRATE
Filing DateThursday, April 2, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, September 21, 2022
Registration Number4970210
Registration DateTuesday, May 31, 2016
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 12, 2016

Trademark Statements

Description of MarkThe mark consists of a stylized curved edge diamond shape comprised of smaller circles. To the right is the wording "TRIFERIC FERRIC PYROPHOSPHATE CITRATE".
Goods and ServicesPreparations for use in clinical and medical dialysis procedures; pharmaceutical solutions used in dialysis and hemodialysis; pharmaceutical preparations, namely, preparations for treating iron deficiency, anemia, kidney disease and renal disease; pharmaceutical preparations for injection, namely, preparations for treating iron deficiency, anemia, kidney disease and renal disease; iron delivery therapy, namely, commercial iron nutritional supplements, intravenous fluids used for the delivery of iron and soluble ferric pyrophosphate, all goods containing ferric pyrophosphate citrate
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"FERRIC PYROPHOSPHATE CITRATE"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 11, 2015
Primary Code005
First Use Anywhere DateThursday, September 3, 2015
First Use In Commerce DateThursday, September 3, 2015

Trademark Owner History

Party NameROCKWELL MEDICAL
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWixom, MI 48393
Party NameROCKWELL MEDICAL
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWixom, MI 48393
Party NameROCKWELL MEDICAL
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWixom, MI 48393

Trademark Events

Event DateEvent Description
Saturday, April 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 14, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, July 10, 2015ASSIGNED TO EXAMINER
Tuesday, July 14, 2015ASSIGNED TO LIE
Tuesday, July 14, 2015COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Wednesday, September 9, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 9, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 10, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 29, 2015WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, December 1, 2015PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, December 2, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 2, 2015EXAMINERS AMENDMENT E-MAILED
Wednesday, December 2, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 6, 2015NEW APPLICATION ENTERED
Tuesday, July 14, 2015EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, July 14, 2015EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, July 14, 2015NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, September 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 9, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 2, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 2, 2015EXAMINER'S AMENDMENT ENTERED
Thursday, December 10, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 24, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, March 18, 2016USE AMENDMENT FILED
Saturday, April 23, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 26, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 12, 2016PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 18, 2016TEAS STATEMENT OF USE RECEIVED
Friday, April 22, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, April 23, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 26, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 31, 2016REGISTERED-PRINCIPAL REGISTER
Monday, May 31, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 21, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 21, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, March 25, 2022TEAS SECTION 8 & 15 RECEIVED
Sunday, June 1, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 21, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

citrate pyrophosphate ferric triferic preparations iron disease namely pharmaceutical anemia kidney dialysis delivery